Cargando…
Editorial: Adaptive immune resistance in cancer therapy
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485827/ https://www.ncbi.nlm.nih.gov/pubmed/37693895 http://dx.doi.org/10.3389/fphar.2023.1277902 |
_version_ | 1785102871606329344 |
---|---|
author | Jiang, Aimin Chen, Ouyang Liu, Zhigang Cai, Hongzhou Wang, Linhui Qi, Lin |
author_facet | Jiang, Aimin Chen, Ouyang Liu, Zhigang Cai, Hongzhou Wang, Linhui Qi, Lin |
author_sort | Jiang, Aimin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10485827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104858272023-09-09 Editorial: Adaptive immune resistance in cancer therapy Jiang, Aimin Chen, Ouyang Liu, Zhigang Cai, Hongzhou Wang, Linhui Qi, Lin Front Pharmacol Pharmacology Frontiers Media S.A. 2023-08-25 /pmc/articles/PMC10485827/ /pubmed/37693895 http://dx.doi.org/10.3389/fphar.2023.1277902 Text en Copyright © 2023 Jiang, Chen, Liu, Cai, Wang and Qi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jiang, Aimin Chen, Ouyang Liu, Zhigang Cai, Hongzhou Wang, Linhui Qi, Lin Editorial: Adaptive immune resistance in cancer therapy |
title | Editorial: Adaptive immune resistance in cancer therapy |
title_full | Editorial: Adaptive immune resistance in cancer therapy |
title_fullStr | Editorial: Adaptive immune resistance in cancer therapy |
title_full_unstemmed | Editorial: Adaptive immune resistance in cancer therapy |
title_short | Editorial: Adaptive immune resistance in cancer therapy |
title_sort | editorial: adaptive immune resistance in cancer therapy |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485827/ https://www.ncbi.nlm.nih.gov/pubmed/37693895 http://dx.doi.org/10.3389/fphar.2023.1277902 |
work_keys_str_mv | AT jiangaimin editorialadaptiveimmuneresistanceincancertherapy AT chenouyang editorialadaptiveimmuneresistanceincancertherapy AT liuzhigang editorialadaptiveimmuneresistanceincancertherapy AT caihongzhou editorialadaptiveimmuneresistanceincancertherapy AT wanglinhui editorialadaptiveimmuneresistanceincancertherapy AT qilin editorialadaptiveimmuneresistanceincancertherapy |